Elizabeth A Swallow Selected Research

Parathyroid Hormone (Parathormone)

1/2022	Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
1/2022	Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease.
1/2021	Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels.
1/2019	Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Swallow Research Topics

Disease

11	Chronic Renal Insufficiency 06/2022 - 01/2019
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2022 - 01/2019
2	Secondary Hyperparathyroidism 06/2022 - 01/2022
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	Hyperphosphatemia 01/2021 - 01/2021
2	Anemia 01/2021 - 01/2020
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2019
1	Bone Resorption 10/2022
1	Azotemia 01/2022
1	Osteogenesis Imperfecta (Lobstein Disease) 04/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Obesity 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2019

Drug/Important Bio-Agent (IBA)

6	MineralsIBA 01/2022 - 01/2019
4	Parathyroid Hormone (Parathormone)IBA 01/2022 - 01/2019
4	Adenine FDA LinkGeneric 04/2021 - 01/2019
3	Fibroblast Growth Factor-23IBA 01/2022 - 01/2020
3	IronIBA 01/2022 - 01/2020
3	Phosphorus (Red Phosphorus)IBA 01/2022 - 01/2019
3	Hormones (Hormone)IBA 01/2021 - 01/2019
2	Diphosphonates (Bisphosphonates)IBA 06/2022 - 10/2019
2	Phosphates (Orthophosphate)IBA 01/2022 - 01/2020
2	ferric citrateIBA 01/2022 - 01/2022
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2019
2	Prolyl-Hydroxylase InhibitorsIBA 01/2021 - 01/2020
2	NitrogenIBA 01/2021 - 01/2019
2	Erythropoietin FDA Link 01/2021 - 01/2020
1	Acid PhosphataseIBA 10/2022
1	Tartrate-Resistant Acid PhosphataseIBA 10/2022
1	Collagen Type I (Type I Collagen)IBA 10/2022
1	Zoledronic Acid (Zometa)FDA Link 06/2022
1	Saccharated Ferric Oxide (Venofer)FDA Link 01/2022
1	etelcalcetide hydrochlorideIBA 01/2022
1	alpha2 Subunit Collagen Type IIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Transferrin (beta 2 Transferrin)IBA 01/2021
1	Chelating AgentsIBA 01/2021
1	molidustatIBA 01/2021
1	Vitamin D3 24-HydroxylaseIBA 01/2020
1	roxadustatIBA 01/2020
1	Carbon MonoxideIBA 01/2020
1	HematinicsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2019
1	CreatinineIBA 01/2019
1	CalciumIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2022
1	Ovariectomy (Oophorectomy) 01/2019